Group One Trading
NERV icon

Group One Trading’s Minerva Neurosciences NERV Stock Holding History

Group One Trading’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,000
Closed -$9.54K – 7685
2022
Q4 		$9.54K Hold
6,000
– – ﹤0.01% 6044
2022
Q3 		$55K Sell
6,000
-26,100
-81% -$155K ﹤0.01% 5325
2022
Q2 		$106K Buy
32,100
+25,950
+422% +$106K ﹤0.01% 4933
2022
Q1 		$41K Sell
6,150
-17,663
-74% -$108K ﹤0.01% 6252
2021
Q4 		$153K Buy
23,813
+5,338
+29% +$50.3K ﹤0.01% 5362
2021
Q3 		$257K Buy
18,475
+9,112
+97% +$137K ﹤0.01% 4913
2021
Q2 		$174K Buy
9,363
+825
+10% +$17.8K ﹤0.01% 5381
2021
Q1 		$199K Sell
8,538
-10,175
-54% -$254K ﹤0.01% 5036
2020
Q4 		$350K Buy
18,713
+5,525
+42% +$139K ﹤0.01% 3593
2020
Q3 		$335K Sell
13,188
-1,837
-12% -$49.7K ﹤0.01% 3215
2020
Q2 		$434K Buy
15,025
+5,325
+55% +$312K ﹤0.01% 2750
2020
Q1 		$467K Buy
9,700
+6,987
+258% +$422K ﹤0.01% 2098
2019
Q4 		$154K Buy
+2,713
New +$120K ﹤0.01% 3346

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Group One Trading's NERV Position: Q1 2023 in Review

Group One Trading sold out of Minerva Neurosciences (NERV) in Q1 2023, closing a stake of 5,785 shares — an estimated $9.2K sold.

Group One Trading first reported a position in NERV in Q3 2016 and held it in 17 quarters. The position peaked at $745K in Q1 2020. 17 funds tracked by Wall St. Rank hold NERV as of Q1 2023.

  • Group One Trading reported no remaining Minerva Neurosciences position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 5,785 Minerva Neurosciences shares in Q1 2023, an estimated $9.2K.
  • Group One Trading first reported a position in Minerva Neurosciences in Q3 2016 and held it in 17 quarters.
  • Group One Trading's Minerva Neurosciences position peaked at $745K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.